Glynn Capital Management LLC boosted its holdings in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 42.7% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 2,733,237 shares of the company's stock after buying an additional 817,518 shares during the period. Oscar Health makes up about 8.7% of Glynn Capital Management LLC's investment portfolio, making the stock its largest position. Glynn Capital Management LLC owned 1.11% of Oscar Health worth $36,735,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of OSCR. Hennessy Advisors Inc. lifted its holdings in shares of Oscar Health by 550.3% during the 4th quarter. Hennessy Advisors Inc. now owns 4,188,400 shares of the company's stock valued at $56,292,000 after acquiring an additional 3,544,300 shares in the last quarter. Westfield Capital Management Co. LP purchased a new position in Oscar Health in the third quarter valued at about $27,452,000. JPMorgan Chase & Co. lifted its stake in shares of Oscar Health by 68.5% during the third quarter. JPMorgan Chase & Co. now owns 2,309,150 shares of the company's stock worth $48,977,000 after purchasing an additional 938,742 shares in the last quarter. Soros Fund Management LLC purchased a new stake in shares of Oscar Health in the third quarter worth about $12,726,000. Finally, Raymond James Financial Inc. acquired a new stake in shares of Oscar Health in the fourth quarter valued at about $6,613,000. 75.70% of the stock is owned by institutional investors and hedge funds.
Oscar Health Stock Performance
Shares of OSCR stock traded up $0.14 on Friday, hitting $13.06. 4,669,292 shares of the stock traded hands, compared to its average volume of 3,657,489. The company has a market capitalization of $3.27 billion, a PE ratio of -652.42 and a beta of 1.75. The company's fifty day moving average is $15.04 and its 200 day moving average is $16.21. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. Oscar Health, Inc. has a 1-year low of $12.43 and a 1-year high of $23.79.
Oscar Health (NYSE:OSCR - Get Free Report) last issued its earnings results on Tuesday, February 4th. The company reported ($0.62) earnings per share for the quarter, missing analysts' consensus estimates of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. On average, equities research analysts predict that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.
Analyst Ratings Changes
Several equities analysts recently commented on OSCR shares. Wells Fargo & Company lowered Oscar Health from an "overweight" rating to an "equal weight" rating and reduced their price target for the stock from $20.00 to $16.00 in a research report on Thursday, March 13th. Jefferies Financial Group initiated coverage on shares of Oscar Health in a research note on Tuesday, December 10th. They issued an "underperform" rating and a $12.00 target price for the company. Two research analysts have rated the stock with a sell rating, three have issued a hold rating, two have issued a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $20.21.
View Our Latest Report on OSCR
Oscar Health Profile
(
Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Featured Articles

Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.